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Bloom’s syndrome is a rare autosomal recessive disor-
der characterized by genomic instability and predispo-
sition to cancer. BLM, the gene defective in Bloom’s
syndrome, encodes a 159-kDa protein possessing DNA-
stimulated ATPase and ATP-dependent DNA helicase
activities. We have examined mechanistic aspects of the
catalytic functions of purified recombinant BLM pro-
tein. Through analyzing the effects of different lengths
of DNA cofactor on ATPase activity, we provide evi-
dence to suggest that BLM translocates along single-
stranded DNA in a processive manner. The helicase re-
action catalyzed by BLM protein was examined as a
function of duplex DNA length. We show that BLM cat-
alyzes unwinding of short DNA duplexes (<71 base pairs
(bp)) but is severely compromised on longer DNA du-
plexes (>259-bp). The presence of the human single-
stranded DNA-binding protein (human replication pro-
tein A (hRPA)) stimulates the BLM unwinding reaction
on the 259-bp partial duplex DNA substrate. Heterolo-
gous single-stranded DNA-binding proteins fail to stim-
ulate similarly the helicase activity of BLM protein. This
is the first demonstration of a functional interaction
between BLM and another protein. Consistent with a
functional interaction between hRPA and the BLM he-
licase, we demonstrate a direct physical interaction be-
tween the two proteins mediated by the 70-kDa subunit
of RPA. The interactions between BLM and hRPA sug-
gest that the two proteins function together in vivo to
unwind DNA duplexes during replication, recombina-
tion, or repair.
Bloom’s syndrome (BS)1 is a rare autosomal recessive disor-
der characterized by pre- and postnatal growth retardation,
immunodeficiency, sun-induced facial erythema, and a greatly
increased predisposition to a wide range of malignant cancers
(1). The most characteristic feature of cells from BS patients is
genomic instability (for review, see Ref. 2). This is manifested
predominantly as an elevated frequency of chromosome breaks
and exchanges (1, 3, 4) as well as a characteristic increase in
the level of reciprocal exchanges between sister chromatids (5).
BS cells exhibit hyper-recombination (1, 6, 7) and abnormali-
ties in DNA replication that include an extended S phase and
accumulation of abnormal replication intermediates compared
with normal cells (8–10).
The gene defective in BS, designated BLM, encodes a protein
of 1417 amino acids with the seven conserved motifs found in
RNA and DNA helicases (7). By sequence alignment, the BLM
gene product belongs to the RecQ subfamily of DNA helicases
that includes a single Escherichia coli DNA helicase named
RecQ, a protein required for the RecF pathway of genetic re-
combination (11) and for suppression of illegitimate recombi-
nation (12). Two yeast proteins, Saccharomyces cerevisiae
Sgs1p (13, 14) and Schizosaccharomyces pombe Rqh1p (15),
belong to the RecQ subfamily and have proposed roles in re-
combination and possibly replication. At present, five human
members of the RecQ subfamily have been identified, including
BLM (7), WRN (16), RecQL (17), RecQL4 (18), and RecQL5
(18). Mutations in the WRN gene are responsible for the pre-
mature aging disorder Werner’s syndrome (16). Most recently,
it was demonstrated that mutations in the RecQL4 gene result
in some cases of Rothmund-Thomson’s syndrome (19). Both
Werner’s syndrome (20, 21) and Rothmund-Thomson’s syn-
drome (22), like BS, are characterized by chromosomal insta-
bility suggesting that DNA helicases are important caretakers
of the human genome with specialized roles in pathways of
DNA metabolism.
Biochemical studies have shown that the BLM protein is a
DNA-stimulated ATPase and ATP-dependent helicase, cata-
lyzing strand displacement of short and medium length oligo-
nucleotides (#91 bp) from partial duplex substrates with a 39 to
59 polarity (23). BLM helicase preferentially unwinds a G4
DNA substrate consisting of four guanine-rich strands stabi-
lized by Hoogsteen bonding (24). Electron microscopy analysis
has shown that BLM protein forms oligomeric rings in solution
(25). Size exclusion chromatography data indicate that the
majority of enzymatically active BLM has an apparent molec-
ular mass of .700 kDa, which is consistent with an oligomeric
structure for BLM (25).
Aside from these structural and biochemical data, molecular
details of the interactions of BLM protein with other proteins
and biological DNA substrates remain to be defined. The mo-
lecular deficiencies involved in the clinical phenotype of BS
presumably reflect an impaired function of the BLM protein in
a pathway of nucleic acid metabolism. Transfection of the wild-
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type BLM gene into BS cells reduces the frequency of sister
chromatid exchanges (26). Mutant alleles of BLM found in
individuals with clinical BS encode BLM protein that is devoid
of DNA helicase activity and fails to reduce the high sister
chromatid exchanges in transfected BS cells (26, 27). These
studies provide evidence that the enzymatic activity of BLM is
important for its cellular function.
In an effort to better understand the mechanistic aspects of
the BLM catalytic activities, we have further characterized the
catalytic activities of the BLM protein. Our results show that
BLM unwinds short DNA duplexes (#71 bp) but is severely
compromised on DNA duplexes $259 bp. The poor unwinding
of BLM helicase on relatively long DNA duplex substrates
suggested to us that additional protein factor(s) might convert
the helicase into a more processive enzyme. A good candidate to
serve as an accessory factor to BLM helicase is the heterotri-
meric single-stranded DNA-binding protein RPA that has been
implicated in replication, recombination, and DNA repair (28).
Evidence indicates that RPA modulates these processes by
specific protein-protein and protein-DNA interactions. We have
recently demonstrated that a specific functional and physical
interaction exists between human RPA and WRN helicase (29).
WRN helicase was found to be capable of unwinding long DNA
duplexes up to 849 bp in a reaction dependent on hRPA. The
notion that RPA may coordinately function with BLM helicase
in vivo is supported by the recent finding that BLM colocalizes
with RPA in meiotic prophase nuclei of mammalian spermato-
cytes (30). Colocalization of BLM and RPA at the synaptonemal
complex of homologously synapsed autosomal bivalents sug-
gests that these foci mark sites of ssDNA synaptic-related
meiotic activity. The interactive roles of BLM and hRPA on
synapsed meiotic bivalents are undefined but likely to involve
the catalytic activity of BLM protein.
In this study we have shown that RPA is required to support
BLM helicase activity on a relatively long DNA duplex of 259-
bp. Two heterologous SSBs, ESSB and gp32, failed to substi-
tute for RPA. This functional interaction was further substan-
tiated by the demonstration of a physical interaction between
hRPA and BLM. This interaction, and colocalization of the two
proteins in meiotic cells, suggests that BLM and RPA function
together in a pathway of DNA metabolism such as recombina-
tion or replication.
MATERIALS AND METHODS
Proteins—Recombinant hexahistidine-tagged BLM protein was over-
expressed in Saccharomyces cerevisiae and purified as described previ-
ously (25). hRPA containing all three subunits (RPA70, RPA32, and
RPA14) was purified as described previously (31). S. cerevisiae replica-
tion protein A (scRPA) was a generous gift of Drs. Dan Bean and Steven
Matson, University of North Carolina, Chapel Hill. ESSB was pur-
chased from Promega. T4 gp32 was from U. S. Biochemical Corp. Re-
striction endonuclease HaeIII was obtained from New England Biolabs.
Klenow enzyme was obtained from Roche Molecular Biochemicals.
DNase I was from Roche Molecular Biochemicals. BSA type V was from
ICN Biochemicals.
Nucleotides and DNA—M13mp18 ssDNA was from New England
Biolabs. The 28-mer oligonucleotide 59-TCCCAGTCACGACGTTGTA-
AAACGACGG-39 was from Life Technologies, Inc. M13mp18 RFI was
prepared as described previously (32). (dT);263 and ATP were from
Amersham Pharmacia Biotech. (dT);900 was from Midland Certified
Reagent Co. [3H]ATP was from Amersham Pharmacia Biotech, and
[a-32P]dCTP was from NEN Life Science Products.
DNA Helicase Substrates—The 71-, 259-, and 851-bp M13mp18 par-
tial duplex substrates were constructed as described previously (29, 33)
with the following modifications. Duplex DNA fragments (69-, 257-, and
849-bp) from the HaeIII digest of M13mp18 replicative form were
purified by polyacrylamide gel electrophoresis and electroelution. The
desired restriction fragment (100 ng) and M13mp18 ssDNA circle (2 mg)
were incubated together in an annealing reaction. The resulting partial
duplex was labeled at its 39 terminus in a fill-in reaction with [32P]dCTP
and Klenow enzyme. The 30-bp M13mp18 partial duplex substrate was
constructed with a 28-mer complementary to positions 6296–6323 in
M13mp18. The 28-mer was annealed to M13mp18 ssDNA circle and
labeled at its 39 end as described above. Partial duplex DNA substrates
were purified by gel filtration column chromatography using Bio-Gel
A-5M resin (Bio-Rad).
DNA Helicase Assay—Helicase assay reaction mixtures (20 ml) con-
tained 50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 5 mM ATP, 100 mg/ml
bovine serum albumin, 50 mM NaCl, and the indicated amounts of BLM
helicase and/or single-stranded DNA-binding protein. The concentra-
tion of the 30-, 71-, 259-, and 851-bp partial duplex helicase substrates
in the reaction mixture was approximately 2 mM (nucleotide). Reactions
were initiated by the addition of BLM protein and incubated at 37 °C for
the indicated times. Reactions were terminated by the addition of 10 ml
of 50 mM EDTA, 40% glycerol, 0.9% SDS, 0.1% bromphenol blue, 0.1%
xylene cyanol. The products of helicase reactions with the 30-, 71-, 259-,
and 851-bp partial duplex substrates were resolved on 12, 8, 6, and 6%
nondenaturing polyacrylamide gels, respectively, as described previ-
ously (29). Radiolabeled DNA species in polyacrylamide gels were visu-
alized using a PhosphorImager or film autoradiography and quanti-
tated using the ImageQuant software (Molecular Dynamics). The
percent helicase substrate unwound was calculated by the following
formula: % displacement 5 100 3 P/(S 1 P). P is the product volume
and S is the substrate volume. The values for P and S have been
corrected after subtracting background values in the no enzyme and
heat-denatured controls, respectively. All helicase data represent the
average of at least three independent determinations.
ATPase Assay—Standard ATPase assay reaction mixtures (30 ml)
contained 50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, the indicated ssDNA
effector (30 mM nucleotide), 0.8 mM [3H]ATP (42 cpm/pmol), 13 nM BLM
protein, and the indicated amounts of hRPA. Reactions were initiated
by the addition of BLM protein and incubated at 37 °C. Samples (5 ml)
were removed at 2-min intervals and evaluated by thin layer chroma-
tography as described previously (34). Less than 20% of the substrate
ATP was consumed in the reaction over the entire time course of the
experiment. The kinetic rate constant (kcat) values were expressed as
the mean of at least three independent determinations.
ELISA Method for Detection of BLM-hRPA Protein-Protein Interac-
tion—hRPA was diluted to a concentration of 1.65 ng/ml in Carbonate
Buffer (0.016 M Na2CO3, 0.034 M NaHCO3 (pH 9.6)). hRPA was then
added to the appropriate wells of a 96-well ELISA plate (100 ml/well)
and allowed to incubate for 2 h at 24 °C. For control experiments, BSA
was substituted for hRPA in the coating step. Wells were aspirated and
washed three times with Wash Buffer (PBS, 0.5% Tween 20). Blocking
Buffer (PBS, 0.5% Tween 20, 3% BSA) was added to appropriate wells
and allowed to incubate 2 h at 24 °C. Wells were aspirated and washed
one time with Blocking Buffer. BLM protein was diluted to 1.0 ng/ml in
Binding Buffer (50 mM Tris-HCl (pH 7.4), 5 mM MgCl2, 5 mM ATP, 100
mg/ml BSA, and 50 mM NaCl, or the indicated NaCl concentration). The
diluted BLM protein was then added to appropriate wells of the ELISA
plate (100 ml/well) and allowed to incubate for 30 min at 24 °C. Wells
were aspirated and washed three times with Binding Buffer. Primary
antibody (rabbit polyclonal IgG against BLM protein) was diluted
1:1000 in Blocking Buffer, added to appropriate wells, and allowed to
incubate 1 h at 24 °C. Wells were aspirated and washed four times with
Blocking Buffer. Secondary antibody (goat anti-rabbit IgG-horseradish
peroxidase) (Jackson ImmunoResearch) was diluted 1:10,000 in Conju-
gate Buffer (50 mM Tris-HCl (pH 8.0), 150 mM NaCl, 0.05% Tween 20,
1% BSA), added to appropriate wells, and allowed to incubate 30 min at
24 °C. Wells were aspirated and washed five times with Conjugate
Buffer. Complexes were detected using K-Blue substrate (Biogen
Corp.). The reaction was terminated after 1 min with 1 N sulfuric acid.
Absorbance readings were taken at 450 nm. The A450 values, corrected
for background signal in the presence of BSA, are expressed as the
mean of three independent determinations.
For DNase I treatment, both BLM protein and hRPA were pretreated
with 20 units of DNase I in Binding Buffer at 37 °C for 15 min. The
proteins were subsequently used in the ELISA as described above.
Under the conditions used for DNase I treatment, 250 ng of control
DNA standard (DNA Molecular Weight Marker II, Roche Molecular
Biochemicals) was completely degraded (,2.5 ng, detectable limit) as
evidenced by SYBR Green Stain (FMC Bioproducts) detection of DNA
electrophoresed on a 1% agarose gel.
Data Analysis—The fraction of the immobilized hRPA bound to the
microtiter well that was specifically bound by BLM protein was deter-
mined from the ELISAs. A Hill plot was used to analyze the data
(Equations 1 and 2).
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Kd 5
~1 2 f!@Pt]
f
(Eq. 1)
log [Pt] 5 log (f/~1 2 f!) 1 log Kd (Eq. 2)
Kd is the dissociation constant of the BLMzhRPA complex, [Pt] is the
total concentration of BLM protein present in the reaction, and f is the
ratio of the amount of the bound hRPA over the total amount of hRPA
in the reaction. The logarithm of [Pt] was plotted against the logarithm
of (f/(1 2 f)), and the y intercept represented the logarithm of Kd.
Far Western Blotting—Far Western blotting analysis was conducted
essentially as described by Wu et al. (35). Previously, a physical inter-
action between BLM and hTOPIIIa was demonstrated (35). In these
studies, the BLM-hTOPIIIa interaction served as a positive control in
experiments to detect a BLM-hRPA interaction. Briefly, 0.2–1.0 mg of
each polypeptide was subjected to SDS-polyacrylamide gel electro-
phoresis and transferred to Hybond-ECL filters (Amersham Pharmacia
Biotech). All subsequent steps were performed at 4 °C. Filters were
immersed twice in denaturation buffer (6 M guanidine HCl in PBSA) for
10 min followed by 6 times for 10 min in serial dilutions (1:1) of
denaturation buffer supplemented with 1 mM dithiothreitol. Filters
were blocked in TBS containing 10% powdered milk, 0.3% Tween 20 for
30 min before being incubated in BLM (0.5 mg/ml) in TBS supplemented
with 0.25% powdered milk, 0.3% Tween 20, 1 mM dithiothreitol, and 1
mM phenylmethylsulfonyl fluoride for 60 min. Filters were washed for 4
times for 10 min in TBS containing 0.3% Tween 20, 0.25% powdered
milk. The second wash contained 0.0001% glutaraldehyde. Conven-
tional Western analysis was then performed to detect the presence of
BLM using BFL-103 (35) as primary antibody. Anti-mouse IgG/horse-
radish peroxidase conjugate (Sigma) was used as secondary antibody at
a 1:10,000 dilution and detected using ECL (Amersham Pharmacia
Biotech) following the manufacturer’s instructions.
RESULTS
Characterization of ATP Hydrolysis Catalyzed by Bloom Pro-
tein—BLM helicase, like all helicases characterized to date,
hydrolyzes nucleoside triphosphate as an energy source for the
unwinding reaction (36). We studied the DNA-stimulated
ATPase activity of BLM protein in the presence of DNA cofac-
tors of varying lengths. Results of these assays are summarized
in Table I. In the absence of a DNA effector, little or no ATP
hydrolysis by BLM protein could be detected using a thin layer
chromatography method to measure conversion of [3H]ATP to
[3H]ADP. These results are consistent with the strong stimu-
lation of ATP hydrolysis by DNA effectors reported by Karow et
al. (23). With the very short (dT)16 oligonucleotide, the turnover
rate constant kcat for ATP hydrolysis was 141 min
21. As the
length of the dT tract was increased to an average length of 263
nt, the kcat increased nearly 6-fold. Increasing the dT tract from
263 to 900 nt resulted in only a modest 1.2-fold increase in the
kcat for ATP hydrolysis. By using M13 ssDNA circles as an
infinitely long DNA effector, the increase in kcat to 1163 min
21
was similarly modest (1.2-fold). However, we cannot rule out
that very long ssDNA molecules would result in a significantly
greater ATPase activity of BLM since the M13 ssDNA circle
contains secondary structure. These data indicate that the
stimulatory effect of DNA molecules on BLM ATP hydrolysis
begins to plateau at a poly(dT) tract length of approximately
263 nt.
The stimulation of BLM protein ATPase activity by a given
DNA concentration (30 mM nucleotide phosphate) was much
greater for long dT tracts (263 and 900). To investigate if the
BLM ATPase reaction was saturated with respect to each DNA
effector, we examined BLM protein ATP hydrolysis in the pres-
ence of a 3-fold greater concentration of nucleotide phosphate
(90 mM) for each DNA effector. The initial rates of BLM ATP
hydrolysis were not increased with the elevated nucleotide
phosphate concentration for each of the DNA effectors (data not
shown). These data provide evidence that the ATPase reaction
is saturated with respect to ssDNA for each DNA effector under
the reaction conditions used.
The data in Table I might be interpreted to suggest that the
free ends of the DNA effector molecules are inhibitory to the
ATP hydrolysis reaction of BLM protein. To address this pos-
sibility, we mixed (dT)16 with either (dT);900 or M13 ssDNA at
a 3:1 molar ratio of nucleotide phosphate and tested the mix-
ture in BLM ATPase reactions. The kcat values for BLM-cata-
lyzed ATP hydrolysis in the presence of the (dT);900 1 (dT)16
mixture or M13 ssDNA 1 (dT)16 mixture were 921 and 1022
min21, respectively (Table I). These data indicate that the BLM
ATPase reaction stimulated by (dT);900 or M13 ssDNA was not
inhibited by the presence of the short (dT)16 molecules, sug-
gesting that the DNA ends do not inhibit ATP hydrolysis.
Effect of Duplex Length on the BLM Helicase Reaction—
Helicases can be classified by the macroscopic reaction mech-
anism for unwinding (36). Duplex unwinding as a function of
duplex length is an important property of each helicase and
may yield insights into the biochemical role of the enzyme in
the cell. By using a variety of DNA substrates, biochemical
studies of purified helicases in vitro have demonstrated that
each DNA unwinding enzyme exhibits its own characteristic
dependence of unwinding on DNA duplex length.
To characterize the effect of duplex length on the unwinding
activity of BLM helicase, we tested partial duplex substrates of
varying length in a strand displacement assay. Unwinding of
M13 partial duplex DNA substrate molecules of 30, 71, 259,
and 851 bp was measured as a function of BLM protein con-
centration (Fig. 1). The figures for percent unwinding of the 30-
(Fig. 1A) and 71-bp (Fig. 1B) substrates rose to 70 and 37% with
4 nM BLM and 92 and 65% with 16 nM BLM (Fig. 1C). Further
increase in amount of BLM helicase in the reaction did not
result in an increase in the percent of DNA unwound for either
substrate. The molecular explanation for the inability to
achieve a greater percentage of the 71-bp partial duplex DNA
substrates unwound is not clear. This phenomenon has been
previously observed for UvrD helicase (33) and may reflect
strand reannealing during the unwinding reaction (discussed
below).
These results demonstrate that BLM helicase is not a very
processive helicase even on short DNA duplexes, since the
fraction of partial duplex molecules unwound exhibits a strict
dependence on length of duplex. Rather, the amount of BLM
helicase that is required in the unwinding reaction for the 30-
and 71-bp partial duplex substrates is proportional to the
length of DNA duplex to be unwound.
It is useful to express the strand displacement data as a rate
of base pairs unwound per min per BLM helicase monomer
(bp/min/BLM monomer). At a BLM concentration of 2 nM, the
rates of duplex unwinding were 0.033 bp/min/BLM monomer
for the 30-bp duplex substrate and 0.039 bp/min/BLM mono-
TABLE I
Hydrolysis of ATP (kcat) catalyzed by BLM in the presence of various
DNA effectors
The BLM concentration was 13 nM (monomer).
DNA effectora kcat
min21
None NDb
(dT)16 141 6 27
(dT);263 822 6 216
(dT);900 956 6 57
M13mp18 ssDNA circle 1163 6 358
(dT);900 1 dT16
c 921 6 82
M13mp18 ssDNA 1 (dT)16
c 1022 6 183
a DNA effector concentration was 30 mM nucleotide phosphate unless
specified otherwise.
b ND, not detectable.
c Concentration of (dT)16 was 90 mM nucleotide phosphate.
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mer for the 71-bp duplex substrate. At a BLM concentration of
4 nM, the rate of unwinding was 0.024 bp/min/BLM monomer
for the 30-bp duplex substrate and 0.030 bp/min/BLM mono-
mer for the 71-bp duplex substrate. Thus, the rates of unwind-
ing (bp unwound/min/BLM monomer) were very similar for
both the 30- and 71-bp partial duplex. Thus the number of base
pairs unwound by BLM helicase for short (#71 bp) partial
duplex DNA substrates depends on the amount of BLM protein
in the reaction as opposed to the length of the duplex unwound.
In contrast to the data described above, the 259- and 851-bp
partial duplex substrates were very poorly unwound by BLM
helicase at all protein concentrations tested. BLM protein dis-
placed less than 2% of the 259-mer DNA fragments on the
helicase substrate (Fig. 1C) and produced no detectable un-
winding of the 851-bp partial duplex substrate (Fig. 1C). In-
creasing the BLM concentration did not result in a proportional
increase of percent substrate unwound (Fig. 1C). The maxi-
mum rate of unwinding (bp unwound/min/BLM monomer) was
13-fold less for the 259-bp partial duplex compared with the
71-bp partial duplex. These results indicate that BLM helicase
unwinds short DNA duplexes (#71 bp) efficiently but is se-
verely compromised in its ability to unwind longer DNA du-
plexes. We conclude that BLM helicase catalyzes a limited
unwinding reaction in vitro.
Specific Stimulation of BLM Helicase Activity by RPA—The
limited unwinding reaction catalyzed by BLM helicase sug-
gests that the enzyme encounters some type of kinetic barrier
that prevents the unwinding of long duplex DNA tracts. Al-
though there are a number of possible explanations for this
result, we sought to test the effect of SSBs on the unwinding
reaction. Previously, we demonstrated that a specific func-
tional and physical interaction exists between WRN helicase
and human replication protein A, which allows the enzyme to
catalyze efficient unwinding of long DNA duplexes (29). Hence,
an additional protein factor such as hRPA may be required to
convert BLM helicase into a more processive enzyme. Alterna-
tively, the poor ability of BLM helicase to unwind long duplex
regions may be due to reannealing of the two strands of the
DNA behind the advancing helicase. In the latter case, an SSB
of any source may be suitable for stimulation of BLM helicase
activity on long DNA duplexes.
To test the effect of the single-stranded DNA-binding pro-
tein, hRPA, on BLM unwinding activity, BLM protein was
incubated with the 259-bp partial duplex in the presence of
different concentrations of hRPA (Fig. 2). BLM protein (32 nM)
alone catalyzed very little detectable unwinding (;3%) of the
259-bp partial duplex DNA substrate. In control reactions,
hRPA (384 nM heterotrimer) alone also did not denature the
259-bp partial duplex DNA substrate (Fig. 2A). However, acti-
vation of BLM helicase activity on the 259-bp partial duplex
could be detected at hRPA concentrations as low as 96 nM
(heterotrimer) (;32% substrate unwound) (Fig. 2, A and B). A
1.5-fold increase in hRPA concentration (144 nM, heterotrimer)
resulted in stimulating BLM helicase activity to 75% substrate
unwound. Maximal unwinding of the 259-bp partial duplex
(82%) was achieved at an hRPA concentration of 192 nM
heterotrimer.
To determine if the stimulatory effect of hRPA on BLM
helicase activity reflected a specific functional interaction be-
tween the two molecules, the effects of ESSB and T4 gp32 on
BLM-catalyzed unwinding of the 259-bp partial duplex were
tested. In control reactions, ESSB (1456 nM homotetramer) or
T4 gp32 (6042 nM monomer) alone did not denature the 259-bp
partial duplex DNA substrate (data not shown). At all concen-
trations tested, neither ESSB (0–1456 nM homotetramer) nor
T4 gp32 (0–6042 nM monomer) stimulated BLM helicase to
unwind the 259-bp duplex over background (data not shown).
To gain insight into the mechanism of stimulation of BLM
helicase activity by hRPA, strand displacement was expressed
as a function of the ratio (R) of SSB-binding units per DNA-
binding site. This analysis takes into account the fact that one
ESSB homotetramer binds 35 nt (37); one gp32 monomer binds
7 nt (37), and one hRPA heterotrimer binds 30 nt (28). The
stimulation of BLM helicase activity on the 259-bp partial
duplex substrate was first detectable at a 1.5-fold excess of
hRPA heterotrimer binding units compared with ssDNA-bind-
ing sites for hRPA (r 5 1.5) (Fig. 2B, inset). At an R value of 2,
the hRPA-stimulated BLM unwinding reaction attained a
value of 75% substrate unwound, approaching the maximum.
FIG. 1. BLM helicase catalyzes a limited unwinding reaction.
Helicase assays were as described under “Materials and Methods”
using the indicated concentration of BLM protein and M13mp18 partial
duplex substrates of 30 bp (A), 71 bp (B), 259 bp (not shown), and 851
bp (not shown). Incubation was at 37 °C for 1 h. Reaction products were
analyzed by nondenaturing gel electrophoresis. , heat-denatured con-
trol. C, quantitation of results from helicase assays. l , 30 bp; E, 71 bp;
3, 259 bp; f, 851 bp. Percent displacement is expressed as a function of
BLM protein concentration.
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In contrast, ESSB failed to stimulate BLM helicase activity at
a 25-fold excess of ESSB binding equivalents over ESSB-bind-
ing sites (data not shown). Likewise, gp32 failed to stimulate
BLM helicase activity at a 21-fold excess of binding units com-
pared with binding sites (data not shown). The fact that both
ESSB and T4 gp32 failed to stimulate unwinding of the long
DNA duplex suggests that a specific interaction between BLM
helicase and hRPA might be responsible for the observed un-
winding of the 259-bp DNA duplex. The unique requirement for
RPA to stimulate BLM-catalyzed unwinding of a long DNA
duplex suggests that this functional interaction may also be
important in vivo.
Effect of S. cerevisiae RPA on BLM Helicase Activity—The
evolutionary conservation of eukaryotic RPA homologues sug-
gests that RPA may have similar functions in DNA metabolism
in eukaryotic organisms (28). However, a number of in vitro
studies have demonstrated that RPA homologues are not func-
tionally equivalent (28, 38). It is presumed that species-specific
interactions of RPA with DNA and other proteins are respon-
sible for the differences. To examine this issue in the context of
BLM function, we tested RPA from S. cerevisiae for its effect on
the BLM helicase reaction. BLM protein (32 nM, monomer) was
incubated with the 259-bp partial duplex in the presence of the
indicated concentrations of scRPA (Fig. 3). In control reactions,
scRPA (300 nM, heterotrimer) alone did not denature the
259-bp partial duplex substrate. At an scRPA concentration of
12.5 nM heterotrimer, approximately 40% of the 259-bp partial
duplex substrate was unwound. The percent substrate un-
wound achieved a maximum of approximately 70% at an scRPA
concentration of 300 nM heterotrimer. These results indicate
that scRPA can effectively substitute for hRPA in the stimula-
tion of BLM helicase activity on a long 259-bp DNA duplex.
Indeed, on a mole for mole basis, scRPA was more effective
than hRPA in stimulating BLM helicase activity at signifi-
cantly lower concentrations than hRPA. There are a number of
possible explanations for the observed differences; for example,
hRPA was overexpressed in E. coli, whereas scRPA was over-
expressed in its native organism, potentially influencing the
specific activity of the two proteins.
Effect of Duplex Length on BLM Helicase Reaction in the
Presence of hRPA—As described above, at concentrations of
BLM protein #4 nM, the rates of unwinding the 30- and the
71-bp partial duplex substrates were very similar in the ab-
sence of hRPA (Fig. 1). However, for longer duplexes (259 and
851 bp), helicase activity was hardly detectable. One of the
possible explanations for the ability of hRPA to stimulate BLM
helicase activity on the 259-bp partial duplex is that hRPA
converts BLM helicase into a more processive enzyme. To ex-
amine more closely the stimulatory effect of hRPA on the BLM
unwinding reaction, we tested the effect of hRPA on BLM
helicase activity using the different length partial duplex DNA
substrates (Fig. 4). The same levels of BLM protein were used
in these experiments as were used to measure unwinding in the
absence of hRPA (Fig. 1). The concentration of hRPA in these
studies was 144 nM heterotrimers, a 2-fold excess of hRPA
binding equivalents over binding sites on the helicase sub-
strate. This concentration of hRPA was chosen because BLM
helicase activity on the 259-bp partial duplex was stimulated
to a near maximum (75% substrate unwound) at this level
(Fig. 2).
The results of BLM protein titrations on the 30-, 71-, 259-,
and 851-bp partial duplex substrates in the presence of hRPA
are shown in Fig. 4. By using the 30-bp partial duplex, signif-
icant unwinding (;77%) was achieved at a relatively low con-
centration of BLM protein (2 nM, monomer). At the same con-
centration of BLM protein, 27% of the 71-bp partial duplex was
unwound. These results show that BLM helicase still exhibits
a protein concentration-dependent reaction mechanism even
on short duplexes since the percent partial duplex substrate
unwound at a given BLM protein concentration is clearly less
for the 71-bp duplex than for the 30-bp duplex. This finding was
further supported by an analysis of the helicase data using the
259-bp partial duplex. Very little unwinding of the 259-bp
partial duplex (,1%) could be detected at a BLM concentration
of 2 nM. Thus, even in the presence of hRPA, the percent
fragment displaced by BLM helicase was significantly reduced
for the 259-bp duplex compared with the shorter 30- and 71-bp
duplexes. These results suggest that even in the presence of
hRPA, the BLM unwinding reaction is compromised on long
DNA duplexes. However, at higher concentrations of BLM pro-
tein, the presence of hRPA stimulates BLM helicase to more
robustly unwind the 259-bp duplex, a finding consistent with
the results presented in Fig. 2. The percent of 259-bp partial
duplex substrate unwound increased proportionately with
BLM protein concentrations. At the highest concentration of
BLM tested, 64 nM monomer, 56% of the 259-bp partial duplex
substrate molecules in the reaction was unwound.
In these experiments, the rate of helicase activity on the
259-bp partial duplex substrate achieves a maximum of 0.014
bp/min/BLM monomer at a BLM protein concentration of 32
nM. This rate is closely matched by similar values of 0.012 and
0.011 bp/min/BLM monomer at BLM concentrations of 16 and
FIG. 2. Stimulation of BLM helicase activity on a 259-bp partial
duplex DNA substrate by hRPA. A, BLM protein (32 nM) was incu-
bated with the 259-bp partial duplex in the presence of the indicated
concentrations of hRPA under standard helicase reaction conditions.
Incubation was at 37 °C for 1 h. B, quantitation of results obtained in A.
Percent displacement is expressed as a function of hRPA concentration.
Inset, quantitation of results obtained in A. Percent displacement is
expressed as a function of the ratio, (SSB binding unit)/(DNA binding
unit).
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64 nM, respectively. The maximal rates of BLM helicase activ-
ity in the presence of hRPA on the 30- and 71-bp partial duplex
substrates were 0.053 and 0.044 bp/min/BLM monomer. This
rate analysis demonstrates a 3.8- and 3.1-fold enhancement of
unwinding the short 30- and 71-bp duplex substrates, respec-
tively, compared with the longer 259-bp substrate. These data
suggest that the efficiency of BLM-catalyzed unwinding is re-
duced even in the presence of hRPA on longer DNA duplex
substrates. However, the presence of hRPA is required to sup-
port BLM helicase activity on DNA duplexes of at least 259 bp.
In contrast to the results with the 259-bp duplex, hRPA had
only a very minor effect on the unwinding activity of BLM on
the 851-bp duplex even at the highest concentration of BLM
tested, 64 nM (Fig. 4). These results suggest that BLM helicase,
even in the presence of hRPA, fails to appreciably unwind very
long DNA duplexes.
BLM Helicase Poorly Unwinds the 851-bp Duplex Over Pro-
longed Incubation—Previously, we demonstrated that hRPA
enables WRN helicase to unwind a long 849-bp partial duplex
DNA substrate in a time-dependent manner (29). To explore
the possibility that BLM helicase could effectively unwind lon-
ger DNA duplexes than 259 bp given sufficiently long periods of
incubation, the BLM helicase was tested for unwinding of the
851-bp partial duplex over a 3-h period in the presence of
hRPA. However, this kinetic analysis of the BLM helicase
reaction demonstrated only slight displacement of the 851-mer
(; 4%) in reactions containing up to 40 nM BLM monomer (data
not shown).
Effect of hRPA on ATPase Activity—To address the mecha-
nism by which hRPA stimulates BLM helicase activity, we
measured the effect of hRPA on ssDNA-stimulated ATPase
activity of BLM (Table II). The turnover rate constant kcat for
ATP hydrolysis by BLM helicase was determined at various
concentrations of hRPA protein and compared with the kcat
value obtained in the absence of hRPA. As shown in Table II,
there was minimal effect of hRPA on kcat values for BLM-
catalyzed ATPase activity using the DNA effector (dT);263. A
modest increase of approximately 1.5-fold was detected at
hRPA concentrations of 32 and 64 nM heterotrimer. Likewise, a
minor increase in BLM-specific ATPase activity was also ob-
served at these concentrations of hRPA using M13mp18 ssDNA
circles as the effector. These results suggest that hRPA does
not significantly increase the specific ATPase activity of BLM
protein. At the highest concentration of hRPA tested, there is a
significant decrease in the ATPase reaction rate using
M13mp18 ssDNA as the effector. This inhibition may reflect
competition between hRPA and BLM helicase for ssDNA-bind-
ing sites on the M13 ssDNA, or inhibition of translocation of
BLM helicase along ssDNA (see “Discussion”). Alternatively, a
physical interaction between BLM and hRPA may inhibit BLM
ATPase activity in the presence of M13 ssDNA, although this
FIG. 4. Stimulatory effect of hRPA on BLM helicase activity is
dependent on duplex length. BLM protein (indicated concentra-
tions) was incubated with the 30- ( l ), 71- (E), 259- (3), and 851-bp (f)
partial duplex DNA substrates in the presence of hRPA (145 nM het-
erotrimer) under standard helicase reaction conditions. Incubation was
at 37 °C for 1 h. Reaction products were analyzed by nondenaturing gel
electrophoresis. Percent displacement is expressed as a function of BLM
protein concentration.
TABLE II
The effect of hRPA on the Kcat for ATP hydrolysis catalyzed by BLM
The concentration of BLM in each reaction was 13 nM.
hRPA
ssDNA effector
M13mp18 Poly(dT);263
nM kcat (min
21)
0 1163 6 358 822 6 216
32 1300 6 278 1204 6 282
64 1407 6 72 1182 6 163
128 830 6 266 862 6 76
256 288 6 46 812 6 115
FIG. 3. S. cerevisiae RPA stimulates
BLM helicase activity. BLM protein (32
nM) was incubated with the 259-bp partial
duplex in the presence of the indicated
concentrations of scRPA under standard
helicase reaction conditions. Incubation
was at 37 °C for 1 h. Percent displacement
is expressed as a function of scRPA con-
centration. Inset, quantitation of results.
Percent displacement is expressed as a
function of the ratio, (SSB binding unit)/
(DNA binding unit).
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does not seem likely since the effect does not occur in the
presence of (dT);263.
BLM Forms a Direct Complex with hRPA ELISA Studies—
The specific functional interaction between hRPA and BLM
helicase suggested to us that the two proteins physically inter-
act with one another. ELISAs were used to test for a protein-
protein interaction. Increasing amounts of BLM protein were
incubated in helicase reaction buffer containing 50 mM NaCl
and 100 mg/ml BSA with hRPA that had been immobilized on
polystyrene microtiter wells. Bound BLM protein was detected
immunologically. As shown in Fig. 5, the colorimetric signal
was both dose-dependent and saturable. The specificity of this
interaction was demonstrated by the absence of color in wells
that had been precoated with BSA rather than hRPA (data not
shown). In control experiments, the colorimetric signal from
the BLM-hRPA interaction was resistant to pretreatment of
both BLM protein and hRPA with DNase I suggesting that a
contaminating DNA bridge is not responsible for the signal
(data not shown). The specific binding of BLM protein to the
hRPA-coated wells was analyzed according to Scatchard bind-
ing theory. The data were analyzed by a Hill plot as described
under “Materials and Methods.” The transformed data were
linear indicating a single set of binding sites for hRPA with
BLM protein. The apparent dissociation constant (Kd) was
determined to be 1.3 nM.
We next examined the salt dependence of the BLM-hRPA
interaction (Fig. 6). 100 ng of BLM protein (6.3 nM, monomer)
was incubated in helicase reaction buffer containing the indi-
cated concentrations of sodium chloride with hRPA that had
been precoated on the microtiter wells. The BLM-hRPA inter-
action was nearly completely resistant to sodium chloride con-
centrations up to 150 mM. The protein interaction was reduced
by 15% at a sodium chloride concentration of 200 mM. Further
reduction in the BLM-hRPA interaction was detected as the
salt concentration was increased up to 400 mM. However, a
significant fraction (30%) of the BLMzhRPA complexes was
resistant to dissociation at sodium chloride concentrations up
to 600 mM.
Far Western Studies—In order to confirm the results of the
ELISA studies, and to identify the subunit(s) of hRPA that
mediates the interaction with BLM, Far Western analysis was
performed (see “Materials and Methods”). For this, hRPA was
immobilized on a nitrocellulose filter, which was then incu-
bated with purified BLM protein. The filter was then washed to
remove unbound protein, and the presence of BLM was de-
tected by conventional Western blotting. As controls, the mem-
brane also contained topoisomerase IIIa, which was very re-
cently shown to bind BLM (35), BSA, and BLM itself.
Moreover, a second filter was prepared containing the same
proteins, which was incubated in buffer alone. Fig. 7 shows
that the anti-BLM antibody detected a band at the position of
the 70-kDa subunit of the hRPA preparation (as well as some
minor degradation products of this subunit), as well as at the
position of the topoisomerase IIIa-positive control. No band
was seen at the positions of either the BSA-negative control or
the 32- and 14-kDa subunits of RPA. The immunoreactivity at
the position of the 70-kDa hRPA subunit was not due to cross-
reactivity of the anti-BLM antiserum with hRPA, because this
band was absent from the control blot that had been incubated
with buffer alone. The BLM present on the control membrane
confirmed that the Western blotting procedure was successful
for each membrane. From these studies, we conclude that BLM
binds to the 70-kDa subunit of hRPA.
DISCUSSION
The cellular and molecular roles of the BLM gene product
remain to be defined and characterized. Recently, it was shown
that missense alleles of Bloom’s syndrome abolish the ATPase
and helicase activities of the BLM protein and fail to correct the
genomic instability of Bloom’s syndrome cells (26, 27). These
findings indicate that the catalytic activities of the BLM pro-
tein play an essential role in the maintenance of genomic
integrity. However, the precise defects in DNA metabolic path-
ways that give rise to the cellular and clinical phenotypes of BS
remain to be elucidated. To understand better the functional
roles of the BLM protein, we have examined the catalytic
activities of the BLM protein and the effect of hRPA on its
activities. The single-stranded DNA-binding protein RPA has
been well characterized and implicated in the processes of
replication, recombination, and repair. The results presented
here suggest that BLM and hRPA are likely to function to-
gether in one of these fundamental processes.
In this study, we demonstrate a functional interaction be-
tween BLM and RPA. hRPA stimulates BLM helicase activity
on DNA duplexes ranging from 30 to 259 bp. scRPA was also
shown to stimulate BLM helicase activity on the 259-bp partial
duplex substrate. A specific interaction between BLM helicase
and RPA is supported by the absolute requirement for RPA in
the BLM-catalyzed unwinding of the 259-bp duplex. Two het-
erologous SSBs, ESSB and T4 gp32, both failed to stimulate
FIG. 5. Detection of a BLMzhRPA complex by ELISA. hRPA-
coated wells (15 nM, heterotrimer, application) were incubated with
increasing amounts of BLM protein for 30 min at 24 °C. Wells were
aspirated and washed three times, and bound BLM protein was de-
tected by ELISA using a rabbit polyclonal antibody against BLM pro-
tein. Absorbance readings at each point were corrected by subtracting a
background A450 reading generated with BSA-coated wells.
FIG. 6. The effect of NaCl concentration on the binding of BLM
protein to immobilized hRPA. Various concentrations of NaCl (0–
600 mM) were included in the initial solution used for incubation of
BLM protein with hRPA bound to the microtiter well. ELISAs were
conducted as described under “Materials and Methods.”
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BLM-catalyzed unwinding of the 259-bp partial duplex as well
as a 71-bp duplex (data not shown). These results suggest that
an additional role of SSB in the BLM-catalyzed helicase reac-
tion is performed by RPA other than simply coating the single
strands generated during DNA duplex unwinding and prevent-
ing reannealing of separated strands.
An important property of DNA helicases is their dependence
of unwinding on duplex length. Many helicases exhibit a lim-
ited reaction mechanism in which the fraction of DNA duplex
molecules unwound decreases substantially as the duplex
length increases (36). Our analysis of helicase activity as a
function of BLM protein concentration on increasing length
DNA duplexes reveals that BLM helicase belongs to this class
of enzymes that catalyze a limited unwinding reaction. Very
little unwinding of the 259- or 851-bp duplexes is detected at
BLM protein concentrations that unwind nearly all of the 30-
or 71-bp substrate molecules. Thus BLM helicase, acting alone,
unwinds only relatively short DNA duplexes.
The limited unwinding reaction of BLM helicase is overcome
by the participation of RPA. Both human and yeast RPA, which
display a high level of homology (28), are able to stimulate the
BLM-catalyzed unwinding reaction. It is possible, therefore,
that RPA interacts functionally with the Sgs1 helicase in yeast.
The effect of hRPA on the BLM helicase reaction is demon-
strated by comparing BLM unwinding activity on different
length DNA duplex substrates in the absence and presence of
hRPA as a function of BLM concentration (Figs. 1 and 4). On
the short 30-bp partial duplex substrate, a small (1.6-fold)
stimulatory effect of hRPA on the BLM helicase reaction was
detected at the lowest concentration of BLM tested, 2 nM mon-
omer. At higher concentrations of BLM, the difference between
reactions in the presence and absence of hRPA was reduced as
the substrate unwound reached a maximum (approximately
90%). On the 71-bp partial duplex, a difference was only de-
tected at higher concentrations of BLM (32 and 64 nM mono-
mer). In the hRPA-supported reaction, the extent of unwinding
the 71-bp duplex reaches .90% substrate unwound compared
with approximately 60% of the substrate unwound in reactions
lacking hRPA. A number of explanations are possible. Based on
the high affinity of hRPA for ssDNA, the difference may partly
reflect inhibition of reannealing of the displaced strand during
unwinding. However, an additional effect of hRPA on BLM
unwinding is evident based on the inability of heterologous
SSBs to stimulate BLM helicase activity on the 71-bp partial
duplex or the 259-bp partial duplex (data not shown).
The most obvious effect of hRPA on BLM helicase activity
was observed with the 259-bp partial duplex. A 17-fold increase
in duplex unwinding was detected at a BLM concentration of
16 nM monomer when hRPA (144 nM, heterotrimer) was pres-
ent, and a 38-fold difference between helicase reactions con-
ducted in the presence versus absence of hRPA was detected at
a BLM concentration of 32 nM monomer. Previously, the long-
est DNA duplex reported to be unwound by BLM helicase was
91 bp. These results demonstrate a functional requirement of
hRPA for BLM-catalyzed unwinding of the 259-bp DNA duplex
substrate. However, hRPA does not stimulate BLM helicase to
unwind effectively the 851-bp partial duplex substrate, even
over a prolonged 3-h incubation. We conclude that the stimu-
latory effect of hRPA on the BLM unwinding activity is limited
to partial duplex substrates of #259 bp, at least under the
reaction conditions described here.
If BLM helicase unwinds substantially long duplex tracts
($851-bp) in vivo, an additional factor is likely to be necessary
for efficient unwinding. The inability of RPA to stimulate BLM-
catalyzed unwinding of the long 851-bp duplex suggests a dif-
ference from the previously demonstrated WRN-RPA interac-
tion. In the WRN-RPA interaction, a significant percentage of
the 849-bp M13 partial duplex was unwound (up to 30% sub-
strate unwound in 2 h) (29). However, the conditions for the
WRN and BLM helicase reactions are different from one an-
other, and we cannot rule out that BLM helicase may be able to
unwind the 851-bp duplex under other reaction conditions.
Specific stimulation of BLM helicase activity by RPA sug-
gests that the two proteins functionally interact. However,
hRPA does not increase the specific ATPase activity of BLM
protein suggesting that the observed increase in helicase activ-
ity is not due to a greater rate of ATP hydrolysis. We did
observe a 4-fold inhibition of BLM ATP hydrolysis in the pres-
ence of the M13 ssDNA circle effector at the highest concentra-
tion of hRPA tested (256 nM heterotrimer) (Table II). At an
hRPA concentration of 256 nM heterotrimer, the ratio of ssDNA
binding equivalents over ssDNA-binding sites (R) in the
ATPase reaction is 0.24. Despite the fact that 75% of the
ssDNA-binding sites would be vacant, it is possible that a
direct competition between hRPA and BLM helicase for bind-
ing sites on the M13mp18 ssDNA circle contributes to the
inhibition of BLM ATPase activity at the very high concentra-
tion of hRPA. The 6–8-fold stimulation of ATP hydrolysis in
the presence of long dT tracts or circular M13 ssDNA molecules
compared with (dT)16 (see Table I) may be explained by the
longer time that BLM protein exists in the DNA-bound state.
The results may be interpreted to suggest that BLM protein
translocates processively along an ssDNA effector. The trans-
location of BLM enzyme along ssDNA may be hindered by the
presence of bound hRPA molecules. However, the inhibitory
effect is specific to the M13 ssDNA circle as it was not observed
with (dT);263. The basis for this difference is not known but
FIG. 7. BLM and hRPA interact via the 70-kDa subunit of hRPA. Purified hRPA, topoisomerase IIIa, BSA and BLM (as indicated above
the lanes) were subjected to SDS-polyacrylamide gel electrophoresis on three identical gels. a, the proteins were stained with Coomassie Blue. b
and c, the proteins were transferred to nitrocellulose membrane and then incubated with either purified BLM (b, 1BLM) or buffer alone (c, 2BLM).
Western blotting using anti-BLM antibody was then used to detect the presence of BLM on each membrane. The positions of the 70-, 32-, and
14-kDa subunits of hRPA are indicated on the left. The positions of the molecular mass standards running parallel are shown on the right.
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may reflect different binding properties of hRPA for the two
DNA effectors.
The unwinding activity of WRN helicase (29) and human
helicase e (39), like BLM, is stimulated by hRPA. However, the
ssDNA-stimulated ATPase activity of these helicases is not
stimulated by hRPA. Although hRPA does not appear to in-
crease the processivity of these enzymes during translocation
along ssDNA, hRPA may play a role in the recruitment of the
helicase to the ssDNA–double-stranded DNA junction of the
ongoing helicase reaction. Consistent with this notion, we
found that the unwinding activity of BLM helicase was not
stimulated by hRPA on a 102-bp blunt duplex DNA substrate
(data not shown). These data would suggest that an ssDNA
loading dock is a requirement for the functional interaction
between BLM helicase and hRPA. In addition, hRPA may
tether BLM helicase to the DNA substrate at the unwinding
fork to facilitate progression of the helicase through relatively
long DNA duplex tracts.
A functional interaction between BLM and hRPA is strongly
supported by our demonstration of a physical interaction be-
tween the two proteins that is mediated via the 70-kDa subunit
of hRPA. ELISA experiments demonstrate that the physical
interaction is saturable and shows a high affinity interaction
between BLM protein and hRPA (Kd 5 1.3 nM). The BLMzhRPA
complex is resistant to salt concentrations up to 200 mM, indi-
cating a fairly stable interaction. The physical interaction be-
tween BLM and hRPA presumably mediates the specific stim-
ulatory effect of hRPA on BLM helicase activity. This is the
first reported functional interaction between BLM helicase and
another protein. WRN protein also exhibits a functional and
physical interaction with hRPA (29), raising the possibility that
the two helicases, defective in two distinct genomic instability
disorders, compete for hRPA in DNA metabolic pathways. Fur-
ther studies are necessary to address the importance of the
WRN/BLM helicase interaction with hRPA and other molecu-
lar partners in pathways defective in these syndromes.
The demonstration of a physical and functional interaction
between BLM and hRPA suggests that the two proteins func-
tion together in some aspect of DNA metabolism in vivo. Re-
cently, BLM protein was shown to colocalize with RPA in
meiotic prophase nuclei of mouse spermatocytes (30). RPA has
been previously shown to play a role in both homologous syn-
apsis and recombination. The appearance of BLM protein is
delayed relative to RPA at the synaptonemal complex, suggest-
ing the involvement of BLM in a late stage of zygotene DNA
replication or meiotic synapsis. The colocalization of BLM pro-
tein and RPA supports the notion that these proteins may
functionally interact to generate ssDNA during meiotic synap-
sis. This suggestion is consistent with the results reported here
that characterize a specific functional and physical interaction
between BLM and hRPA.
The elevated sister chromatid exchange and hyper-recombi-
nation associated with BS suggest a defect in recombination.
However, a replication defect may be primarily responsible for
the genomic instability. BS fibroblasts display reduced replica-
tion fork progression and the accumulation of abnormal repli-
cation intermediates (10). BLM helicase (and other RecQ fam-
ily helicases) have been proposed to be important to overcome
structural abnormalities that arise during replication (2). It is
conceivable that BLM helicase and RPA act together to unwind
various types of nucleic acid structures at the replication fork,
thereby facilitating efficient DNA replication or recombination.
The specific interaction between BLM and hRPA suggests that
these proteins are likely to function coordinately in vivo. The
characteristic cellular and clinical phenotypes of BS suggest
that unique interactions of BLM protein with DNA and cellular
proteins such as RPA are critical to the biological function of
the BLM-catalyzed unwinding reaction necessary to maintain
genomic integrity in vivo.
Acknowledgments—We thank the Danish Center for Molecular
Gerontology for interactions. We thank Brian Howard of Paragon
Bioservices for technical assistance in the ELISA studies.
REFERENCES
1. German, J. (1993) Medicine (Baltimore) 72, 393–406
2. Chakraverty, R. K., and Hickson, I. D. (1999) BioEssays 21, 286–294
3. Ellis, N. A., and German, J. (1996) Hum. Mol. Genet. 5, 1457–1463
4. Watt, P. M., Hickson, I. D., Borts, R. H., and Louis, E. J. (1996) Genetics 144,
935–945
5. Langlois, R. G., Bigbee, W. L., Jensen, R. H., and German, J. (1989) Proc. Natl.
Acad. Sci. U. S. A. 86, 670–674
6. Cheng, R. Z., Murano, S., Kurz, B., and Shmookler, R. R. (1990) Mutat. Res.
237, 259–269
7. Ellis, N. A., Groden, J., Ye, T. Z., Straughen, J., Lennon, D. J., Ciocci, S.,
Proytcheva, M., and German, J. (1995) Cell 83, 655–666
8. Gianneli, F., Benson, P. F., Pawsey, S. A., and Polani, P. E. (1977) Nature 265,
466–469
9. Hanaoka, F., Yamada, M., Takeuchi, F., Goto, M., Miyamoto, T., and Hori, T.
(1985) Adv. Exp. Med. Biol. 190, 439–457
10. Lonn, U., Lonn, S., Nylen, U., Winblad, G., and German, J. (1990) Cancer Res.
50, 3141–3145
11. Nakayama, K., Irino, N., and Nakayama, H. (1985) Mol. Gen. Genet. 200,
266–271
12. Hanada, K., Ukita, T., Kohno, Y., Saito, K., Kato, J., and Ikeda, H. (1997) Proc.
Natl. Acad. Sci. U. S. A. 94, 3860–3865
13. Gangloff, S., McDonald, J. P., Bendixen, C., Arthur, L., and Rothstein, R.
(1994) Mol. Cell. Biol. 14, 8391–8398
14. Watt, P. M., Louis, E. J., Borts, R. H., and Hickson, I. D. (1995) Cell 81,
253–260
15. Stewart, E., Chapman, C. R., Al-Khodairy, F., Carr, A. M., and Enoch, T.
(1997) EMBO J. 16, 2682–2692
16. Yu, C. E., Oshima, J., Fu, Y. H., Wijsman, E. M., Hisama, F., Alisch, R.,
Matthews, S., Nakura, J., Miki, T., Ouais, S., Martin, G. M., Mulligan, J.,
and Schellenberg, G. D. (1996) Science 272, 258–262
17. Seki, M., Miyazawa, H., Tada, S., Yanagisawa, J., Yamaoka, T., Hoshino, S.,
Ozawa, K., Eki, T., Nogami, M., and Okumura, K. (1994) Nucleic Acids Res.
22, 4566–4573
18. Kitao, S., Ohsugi, I., Ichikawa, K., Goto, M., Furuichi, Y., and Shimamoto, A.
(1998) Genomics 54, 443–452
19. Kitao, S., Shimamoto, A., Goto, M., Miller, R. W., Smithson, W. A., Lindor,
N. M., and Furuichi, Y. (1999) Nat. Genet. 22, 82–84
20. Salk, D., Bryant, E., Hoehn, H., Johnston, P., and Martin, G. M. (1985) Adv.
Exp. Med. Biol. 190, 305–311
21. Salk, D., Au, K., Hoehn, H., and Martin, G. M. (1981) Cytogenet. Cell Genet. 30,
92–107
22. Lindor, N. M., Devries, E. M., Michels, V. V., Schad, C. R., Jalal, S. M.,
Donovan, K. M., Smithson, W. A., Kvols, L. K., Thibodeau, S. N., and
Dewald, G. W. (1996) Clin. Genet. 49, 124–129
23. Karow, J. K., Chakraverty, R. K., and Hickson, I. D. (1997) J. Biol. Chem. 272,
30611–30614
24. Sun, H., Karow, J. K., Hickson, I. D., and Maizels, N. (1998) J. Biol. Chem. 273,
27587–27592
25. Karow, J. K., Newman, R. H., Freemont, P. S., and Hickson, I. D. (1999) Curr.
Biol. 9, 597–600
26. Neff, N. F., Ellis, N. A., Ye, T. Z., Noonan, J., Huang, K., Sanz, M., and
Proytcheva, M. (1999) Mol. Biol. Cell 10, 665–676
27. Bahr, A., De Graeve, F., Kedinger, C., and Chatton, B. (1998) Oncogene 17,
2565–2571
28. Wold, M. S. (1997) Annu. Rev. Biochem. 66, 61–92
29. Brosh, R. M., Jr., Orren, D. K., Nehlin, J. O., Ravn, P. H., Kenny, M. K.,
Machwe, A., and Bohr, V. A. (1999) J. Biol. Chem. 274, 18341–18350
30. Walpita, D., Plug, A. W., Neff, N. F., German, J., and Ashley, T. (1999) Proc.
Natl. Acad. Sci. U. S. A. 96, 5622–5627
31. Kenny, M. K., Schlegel, U., Furneaux, H., and Hurwitz, J. (1990) J. Biol.
Chem. 265, 7693–7700
32. Lechner, R. L., and Richardson, C. C. (1983) J. Biol. Chem. 258, 11185–11196
33. Matson, S. W., and George, J. W. (1987) J. Biol. Chem. 262, 2066–2076
34. Matson, S. W., and Richardson, C. C. (1983) J. Biol. Chem. 258, 14009–14016
35. Wu, L., Davies, S. L., North, P. S., Goulaouic, H., Riou, J.-F., Turley, H.,
Gatter, K. C., and Hickson, I. D. (2000) J. Biol. Chem. 275, 9636–9646
36. Matson, S. W., Bean, D. W., and George, J. W. (1994) BioEssays 16, 13–22
37. Lohman, T. M., and Ferrari, M. E. (1994) Annu. Rev. Biochem. 63, 527–570
38. Sibenaller, Z. A., Sorensen, B. R., and Wold, M. S. (1998) Biochemistry 37,
12496–12506
39. Seo, Y. S., Lee, S. H., and Hurwitz, J. (1991) J. Biol. Chem. 266, 13161–13170
Interaction between BLM and hRPA23508
 at U
N
IV
ERSITY
 O
F PLY
M
O
U
TH
 on N
ovem
ber 27, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
Raichal P. Kureekattil, Ian D. Hickson and Vilhelm A. Bohr
Robert M. Brosh, Jr., Ji-Liang Li, Mark K. Kenny, Julia K. Karow, Marcus P. Cooper,
Stimulates Its Helicase Activity
Replication Protein A Physically Interacts with the Bloom's Syndrome Protein and
doi: 10.1074/jbc.M001557200 originally published online May 23, 2000
2000, 275:23500-23508.J. Biol. Chem. 
  
 10.1074/jbc.M001557200Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/275/31/23500.full.html#ref-list-1
This article cites 39 references, 18 of which can be accessed free at
 at U
N
IV
ERSITY
 O
F PLY
M
O
U
TH
 on N
ovem
ber 27, 2017
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
